Senti Biosciences | 4: Statement of changes in beneficial ownership of securities-Director Mathers Edward T
Senti Biosciences | 4: Statement of changes in beneficial ownership of securities-Director Farokhzad Omid
Senti Biosciences | 4: Statement of changes in beneficial ownership of securities-Director COOPERSTONE BRENDA
Senti Biosciences | 4: Statement of changes in beneficial ownership of securities-Director Collins James J.
Senti Biosciences | 3: Initial statement of beneficial ownership of securities-Officer Li Yvonne
Senti Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer Rajangam Kanya
Senti Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer Lu Timothy K
Senti Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer KNOBELMAN DEBORAH
Senti Biosciences | 4: Statement of changes in beneficial ownership of securities-Director Mathers Edward T
Senti Biosciences | 4: Statement of changes in beneficial ownership of securities-Director Berland Susan D
Senti Biosciences | 4: Statement of changes in beneficial ownership of securities-Director Collins James J.
Senti Biosciences | 4: Statement of changes in beneficial ownership of securities-Director COOPERSTONE BRENDA
Senti Biosciences | 4: Statement of changes in beneficial ownership of securities-Director Farokhzad Omid
Senti Biosciences | SC 13G: Statement of acquisition of beneficial ownership by individuals-T. ROWE PRICE ASSOCIATES, INC.(8.1%)
Senti Biosciences | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Sculptor Capital LP(0.00%),Sculptor Capital II LP(0.00%), etc.
Senti Biosciences | SC 13G: Statement of acquisition of beneficial ownership by individuals-Bayer HealthCare LLC(13.4%),Bayer US Holding LP(13.4%), etc.
Senti Biosciences | 3: Initial statement of beneficial ownership of securities-10% Owner BAYER HEALTHCARE LLC
Senti Biosciences | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Woodline Partners LP(0%)
Senti Biosciences | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Morgan Stanley(0.6%),Morgan Stanley Invesment Management Inc.(0.6%), etc.
Senti Biosciences | SC 13G: Statement of acquisition of beneficial ownership by individuals-8VC GP I, LLC(5.8%),Joe Lonsdale(5.8%), etc.
No Data